Clinical Trial Update: Epidiolex and Drug Resistant Epilepsy in Children

View source ↗

Summary

This entry notes an ongoing clinical trial evaluating Epidiolex (cannabidiol) for drug-resistant epilepsy in children, with Augusta University as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• EPIDIOLEX (Cannabidiol)

Snippet

Sponsor: Augusta University | Conditions: Epilepsy | Status: AVAILABLE